CVKD · Cadrenal Therapeutics, Inc. · Documents
$0.94
0.00 (-0.47%)
At close · Oct 29
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.38M
Shares
3.57M
Volume · Oct 29
44.03K
Avg daily vol (3M)
461.96K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Cadrenal Therapeutics initiated a formal strategic process on October 7, 2026 to evaluate asset licensing or sales, partnerships, portfolio transactions and business combinations. It has no completion timetable. | 2026-10-07 | — | |
| 8-K | Cadrenal Therapeutics, Inc. stockholders increased the 2022 Plan share reserve by 323,542 shares to 1,000,000, authorized issuance of up to 960,000 shares upon Series C-1 warrant exercises, and elected Quang X. Pham as a Class I director. | 2026-09-29 | 2026-09-24 | |
| 8-K | — | 2026-08-31 | — | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| ARS | — | 2026-08-03 | 2025-12-31 | |
| DEF 14A | — | 2026-08-03 | 2026-09-24 | |
| DEFA14A | — | 2026-08-03 | — | |
| PRE 14A | — | 2026-07-23 | — | |
| 8-K | — | 2026-07-21 | — | |
| 8-K | — | 2026-07-17 | 2026-07-14 | |
| S-3 | — | 2026-07-13 | — | |
| 8-K | — | 2026-07-10 | 2026-07-07 | |
| 8-K | — | 2026-07-01 | 2026-06-30 | |
| 8-K | — | 2026-06-29 | 2026-06-25 | |
| 8-K | — | 2026-06-18 | — | |
| 8-K | — | 2026-06-03 | 2026-05-28 | |
| Investor Event Transcript | — | 2026-05-28 | 2026-06-30 | |
| 8-K | — | 2026-05-07 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| 8-K | — | 2026-04-30 | — | |
| S-3 | — | 2026-04-21 | — | |
| 8-K | — | 2026-04-01 | 2026-03-31 | |
| 8-K | — | 2026-03-31 | — | |
| 10-K | — | 2026-03-31 | 2025-12-31 | |
| 8-K | — | 2026-03-12 | — | |
| 8-K | — | 2026-02-24 | — | |
| S-1 | — | 2025-12-29 | — | |
| 8-K | — | 2025-12-23 | — | |
| 8-K | — | 2025-12-16 | 2025-12-15 | |
| 8-K | — | 2025-12-11 | 2025-12-10 | |
| 8-K | — | 2025-12-01 | 2025-11-24 | |
| 8-K | — | 2025-11-18 | — | |
| 8-K | — | 2025-11-10 | — | |
| 10-Q | — | 2025-11-10 | 2025-09-30 | |
| Investor Event Transcript | — | 2025-09-30 | — | |
| 8-K | — | 2025-09-24 | — | |
| 8-K | — | 2025-09-15 | 2025-09-12 | |
| 8-K | — | 2025-08-11 | — | |
| 10-Q | — | 2025-08-11 | 2025-06-30 | |
| 8-K | — | 2025-08-05 | — | |
| DEF 14A | — | 2025-07-31 | 2025-09-24 | |
| DEFA14A | — | 2025-07-31 | — | |
| ARS | — | 2025-07-31 | 2024-12-31 | |
| 8-K | — | 2025-07-18 | 2025-07-15 | |
| 8-K | — | 2025-05-08 | — | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| 8-K | — | 2025-04-17 | — | |
| 10-K | — | 2025-03-13 | 2024-12-31 | |
| 8-K | — | 2025-03-13 | — |
Showing 1–50 of 107 filings